CLASS III ONGOING Device recall · Reported 6 Nov 2024 · FDA Enforcement Report

Insight Base Flex recalled by Trackx Technology

Trackx Technology is recalling Insight Base Flex - 8, distributed in Florida, North Carolina, New York, Pennsylvania, Virginia. The recall was initiated on 3 Sep 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesGTIN: 00857088008493, Lot: 2404002, Expiration Date: 04/01/2027
Quantity recalled82

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0260-2025
FDA event ID
95424
Recalling firm
Trackx Technology, Hillsborough, NC
Classification
Class III
Status
Ongoing
Recall initiated
3 Sep 2024
FDA classified
30 Oct 2024
Reported
6 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

3 Sep 2024Recall initiated by company
30 Oct 2024Classified by FDA+57 days
6 Nov 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The patient label stickers may have the wrong expiration date recorded. The contract manufacturer entered the manufacturing date (2024-04-01) as the expiration date. The actual expiration date of the product is 2027-04-01. This is reflected on the carton label and sterile pouch label correctly.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Product Name: Insight Base Flex - 8, Ref 608-3TX; The device consists of a sterile Snap that includes reflective features that facilitate imaging of the (attached) instrument using instrument tracking technology when used with a compatible tracking system. Each TrackX¿ Snap has a unique set of 2 or more reflective markers. By having unique configurations of reflective markers, it is possible to identify which TrackX Snap is in the field of view of the camera(s). As such, it is also possible to have multiple TrackX Snaps in the field at once and to have different TrackX Snaps for different surgical instruments. The device is considered to be a sterile accessory.

Where it was distributed

NC, VA, FL, PA, NY

FloridaNorth CarolinaNew YorkPennsylvaniaVirginia

Questions about this recall

Why was it recalled?

The patient label stickers may have the wrong expiration date recorded. The contract manufacturer entered the manufacturing date (2024-04-01) as the expiration date. The actual expiration date of the product is 2027-04-01. This is reflected on the carton label and sterile pouch label correctly.

Which lots are affected?

GTIN: 00857088008493, Lot: 2404002, Expiration Date: 04/01/2027

Where was it sold?

NC, VA, FL, PA, NY

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Trackx Technology

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IITrackX Insight Base Modular Instrument Tracker recalledTrackx TechnologyDevice MalfunctionNationwide

Other Surgical Instruments recalls

All 3,891